Showing 49 to 60 of 171 results
Medicare Drug Price Negotiations Continue Under Trump Administration
The Trump administration is continuing Medicare's drug price negotiations begun under Biden, with initial offers sent to Novo Nordisk and Amgen for 15 drugs; lower prices are expected to start in January 2027.
Medicare Drug Price Negotiations Continue Under Trump Administration
The Trump administration is continuing Medicare's drug price negotiations begun under Biden, with initial offers sent to Novo Nordisk and Amgen for 15 drugs; lower prices are expected to start in January 2027.
Progress
36% Bias Score
Removing Fluoride from US Water: 25 Million More Decayed Teeth, $9.8 Billion Cost Projected
A new study estimates that removing fluoride from US public water would cause 25.4 million additional decayed teeth in children within five years, costing $9.8 billion in healthcare; these numbers would more than double within 10 years, disproportionately impacting low-income families.
Removing Fluoride from US Water: 25 Million More Decayed Teeth, $9.8 Billion Cost Projected
A new study estimates that removing fluoride from US public water would cause 25.4 million additional decayed teeth in children within five years, costing $9.8 billion in healthcare; these numbers would more than double within 10 years, disproportionately impacting low-income families.
Progress
52% Bias Score
Canadian Employers Expand Employee Benefits to Address Mental Health, Wellness, and Family Planning
Canadian employers are expanding employee benefits to include flexible spending accounts, increased mental health coverage, virtual healthcare options, and fertility treatments, reflecting a growing focus on employee well-being and cost-effectiveness.
Canadian Employers Expand Employee Benefits to Address Mental Health, Wellness, and Family Planning
Canadian employers are expanding employee benefits to include flexible spending accounts, increased mental health coverage, virtual healthcare options, and fertility treatments, reflecting a growing focus on employee well-being and cost-effectiveness.
Progress
32% Bias Score
German Long-Term Care Insurance Faces €3.5 Billion Deficit by 2026
Germany's long-term care insurance faces a €1.65 billion deficit this year, rising to €3.5 billion by 2026, necessitating a contribution increase unless new funding is secured; this is driven by rising costs and an aging population.
German Long-Term Care Insurance Faces €3.5 Billion Deficit by 2026
Germany's long-term care insurance faces a €1.65 billion deficit this year, rising to €3.5 billion by 2026, necessitating a contribution increase unless new funding is secured; this is driven by rising costs and an aging population.
Progress
56% Bias Score
Greek Bank Criticizes Private Hospital Pricing, Leading to Cost Control Measures
The Bank of Greece criticizes private hospitals in Greece for their pricing model, which incentivizes unnecessary tests and inflates insurance claim costs, prompting the National Insurance Company to pilot a new system to control costs.
Greek Bank Criticizes Private Hospital Pricing, Leading to Cost Control Measures
The Bank of Greece criticizes private hospitals in Greece for their pricing model, which incentivizes unnecessary tests and inflates insurance claim costs, prompting the National Insurance Company to pilot a new system to control costs.
Progress
44% Bias Score
Trump's Executive Order Seeks to Lower U.S. Drug Prices Amidst Global Pricing Imbalance
Donald Trump issued an executive order on Monday aiming to lower U.S. drug prices by 30-80%, following a Sunday Truth Social post; however, the plan faces legal and practical challenges, given the high profit margins and political influence of the pharmaceutical industry and the complex global prici...
Trump's Executive Order Seeks to Lower U.S. Drug Prices Amidst Global Pricing Imbalance
Donald Trump issued an executive order on Monday aiming to lower U.S. drug prices by 30-80%, following a Sunday Truth Social post; however, the plan faces legal and practical challenges, given the high profit margins and political influence of the pharmaceutical industry and the complex global prici...
Progress
48% Bias Score
Trump's Drug Pricing Order Faces Implementation Hurdles
President Trump's executive order mandates that the US pay the lowest price for drugs among peer nations, but implementation faces significant challenges due to logistical complexities, legal uncertainties, and past failures of similar initiatives.
Trump's Drug Pricing Order Faces Implementation Hurdles
President Trump's executive order mandates that the US pay the lowest price for drugs among peer nations, but implementation faces significant challenges due to logistical complexities, legal uncertainties, and past failures of similar initiatives.
Progress
40% Bias Score
Spain Tackles Vitamin D Overuse: Hospital Initiative Cuts Tests, Costs
A significant increase in vitamin D testing and supplement use in Spain, driven by unsubstantiated claims, resulted in 190 overdose reports (100 severe, nearly half hospitalized). A Cantabria hospital's initiative reduced tests by 40% and costs by 48% in 9 months through evidence-based protocols.
Spain Tackles Vitamin D Overuse: Hospital Initiative Cuts Tests, Costs
A significant increase in vitamin D testing and supplement use in Spain, driven by unsubstantiated claims, resulted in 190 overdose reports (100 severe, nearly half hospitalized). A Cantabria hospital's initiative reduced tests by 40% and costs by 48% in 9 months through evidence-based protocols.
Progress
40% Bias Score
Italian Celiac Patients Face Economic Hardship Due to Price Discrepancies and Uneven Regional Support
A study in Italy reveals significant price differences in gluten-free products across supermarkets, specialized stores, and pharmacies, impacting the 265,102 diagnosed celiac patients and an estimated 600,000 more awaiting diagnosis, particularly given inconsistent regional financial support.
Italian Celiac Patients Face Economic Hardship Due to Price Discrepancies and Uneven Regional Support
A study in Italy reveals significant price differences in gluten-free products across supermarkets, specialized stores, and pharmacies, impacting the 265,102 diagnosed celiac patients and an estimated 600,000 more awaiting diagnosis, particularly given inconsistent regional financial support.
Progress
20% Bias Score
Spain's Aging Population: A Looming Economic Crisis
Spain's aging population, with a rapidly increasing proportion of citizens over 65, is severely impacting the labor market, pension system, and public finances, demanding urgent structural reforms for long-term economic stability.
Spain's Aging Population: A Looming Economic Crisis
Spain's aging population, with a rapidly increasing proportion of citizens over 65, is severely impacting the labor market, pension system, and public finances, demanding urgent structural reforms for long-term economic stability.
Progress
56% Bias Score
Trump's Misplaced Blame for High U.S. Drug Prices
President Trump wrongly blamed high U.S. prescription drug prices on foreign nations; a RAND report showed U.S. prices were 2.78 times higher than in 33 other countries in 2022 due to the fragmented U.S. drug pricing system, prompting an executive order to tie U.S. prices to lower prices abroad.
Trump's Misplaced Blame for High U.S. Drug Prices
President Trump wrongly blamed high U.S. prescription drug prices on foreign nations; a RAND report showed U.S. prices were 2.78 times higher than in 33 other countries in 2022 due to the fragmented U.S. drug pricing system, prompting an executive order to tie U.S. prices to lower prices abroad.
Progress
40% Bias Score
Diabetes-Related Cardiovascular Deaths Rise in England
A Diabetes UK report reveals that 29% of cardiovascular deaths in England in 2022 were in people with diabetes, up from 15% in 2009, costing the UK £10.7bn annually with projected costs rising to £18bn by 2035, while only 61.3% received all recommended care processes.
Diabetes-Related Cardiovascular Deaths Rise in England
A Diabetes UK report reveals that 29% of cardiovascular deaths in England in 2022 were in people with diabetes, up from 15% in 2009, costing the UK £10.7bn annually with projected costs rising to £18bn by 2035, while only 61.3% received all recommended care processes.
Progress
36% Bias Score
Showing 49 to 60 of 171 results